Briacell Therapeutics Corp Stock Analysis

BCTXW Stock  USD 0.34  0.06  18.97%   
BriaCell Therapeutics Corp is overvalued with Real Value of 0.27 and Hype Value of 0.38. The main objective of BriaCell Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what BriaCell Therapeutics Corp is worth, separate from its market price. There are two main types of BriaCell Therapeutics' stock analysis: fundamental analysis and technical analysis.
The BriaCell Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. BriaCell Therapeutics is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. BriaCell Stock trading window is adjusted to America/New York timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BriaCell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

BriaCell Stock Analysis Notes

The company had not issued any dividends in recent years. For more info on BriaCell Therapeutics Corp please contact William MD at 604-921-1810 or go to https://briacell.com.

BriaCell Therapeutics Investment Alerts

BriaCell Therapeutics is way too risky over 90 days horizon
BriaCell Therapeutics has some characteristics of a very speculative penny stock
BriaCell Therapeutics appears to be risky and price may revert if volatility continues
BriaCell Therapeutics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.93 M) with profit before overhead, payroll, taxes, and interest of 0.
BriaCell Therapeutics generates negative cash flow from operations
BriaCell Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from gurufocus.com: BriaCell Provides Update to its Board of Directors

BriaCell Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 48.08 M.

BriaCell Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.68)(0.64)
Return On Capital Employed(1.06)(1.11)
Return On Assets(0.67)(0.64)
Return On Equity 4.84  5.08 

Management Efficiency

BriaCell Therapeutics has return on total asset (ROA) of (1.2611) % which means that it has lost $1.2611 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.0601) %, meaning that it generated substantial loss on money invested by shareholders. BriaCell Therapeutics' management efficiency ratios could be used to measure how well BriaCell Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 5.08 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.64). At this time, BriaCell Therapeutics' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 1.3 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.2 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share(0.28)(0.26)
Net Current Asset Value402 K357.4 K
Tangible Asset Value675.2 K628.6 K
Tangible Book Value Per Share(0.29)(0.28)
Enterprise Value Over EBITDA(3.44)(3.62)
Price Book Value Ratio(31.28)(29.72)
Enterprise Value Multiple(3.44)(3.62)
Price Fair Value(31.28)(29.72)
Enterprise Value73.4 M77 M
The management strategies employed by BriaCell Therapeutics' are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Beta
1.816
Return On Assets
(1.26)
Return On Equity
(2.06)

Technical Drivers

As of the 28th of November, BriaCell Therapeutics shows the Downside Deviation of 12.93, risk adjusted performance of 0.0455, and Mean Deviation of 8.22. BriaCell Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BriaCell Therapeutics semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if BriaCell Therapeutics is priced correctly, providing market reflects its regular price of 0.345 per share. As BriaCell Therapeutics appears to be a penny stock we also recommend to validate its total risk alpha numbers.

BriaCell Therapeutics Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BriaCell Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BriaCell Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

BriaCell Therapeutics Predictive Daily Indicators

BriaCell Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BriaCell Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

BriaCell Therapeutics Forecast Models

BriaCell Therapeutics' time-series forecasting models are one of many BriaCell Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BriaCell Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About BriaCell Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how BriaCell Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BriaCell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BriaCell Therapeutics. By using and applying BriaCell Stock analysis, traders can create a robust methodology for identifying BriaCell entry and exit points for their positions.
Last ReportedProjected for Next Year

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BriaCell Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Additional Tools for BriaCell Stock Analysis

When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.